Mohammad Abu Hilal1, Luca Aldrighetti2, Ibrahim Dagher3, Bjorn Edwin4, Roberto Ivan Troisi5, Ruslan Alikhanov6, Somaiah Aroori7, Giulio Belli8, Marc Besselink9, Javier Briceno10, Brice Gayet11, Mathieu D'Hondt12, Mickael Lesurtel13, Krishna Menon14, Peter Lodge15, Fernando Rotellar16, Julio Santoyo17, Olivier Scatton18, Olivier Soubrane19, Robert Sutcliffe20, Ronald Van Dam21, Steve White22, Mark Christopher Halls1, Federica Cipriani2, Marcel Van der Poel9, Ruben Ciria10, Leonid Barkhatov4, Yrene Gomez-Luque10, Sira Ocana-Garcia10, Andrew Cook23, Joseph Buell24, Pierre-Alain Clavien25, Christos Dervenis26, Giuseppe Fusai27, David Geller28, Hauke Lang29, John Primrose1, Mark Taylor30, Thomas Van Gulik9, Go Wakabayashi31, Horacio Asbun32, Daniel Cherqui33. 1. University Hospital Southampton, Southampton, UK. 2. San Raffaele Hospital, Milan, Italy. 3. Antoine-Beclere Hospital, Paris, France. 4. The Intervention Centre, Department of HBP surgery, Oslo University Hospital and Institute of Clinical Medicine, Oslo University, Oslo, Norway. 5. Gent University Hospital Medical School, Gent, Belgium. 6. Moscow Clinical Scientific Centre, Moscow, Russia. 7. Plymouth Hospital NHS Trust, Plymouth, UK. 8. Loreto Nuovo Hospital, Naples, Italy. 9. Academic Medical Centre, Amsterdam, Netherlands. 10. University Hospital Reina, Sofia Cordoba, Spain. 11. Institut Mutualiste Montsouris, Paris, France. 12. AZ Groeninge, Kortrijk, Belgium. 13. Croix Rousse University Hospital, Lyon, France. 14. King's College Hospital, London, UK. 15. Leeds Teaching Hospitals NHS Trust, Leeds, UK. 16. Navarra University, Pamplona, Spain. 17. Malaga University Hospital, Malaga, Spain. 18. Pierre and Marie Curie University, Paris, France. 19. Beaujon Hospital, Clichy, France. 20. University Hospital Birmingham, Birmingham, UK. 21. Maastricht University Medical Centre, Maastricht, Nehterlands. 22. Newcastle upon Tyne NHS Foundation Trust, Newcastle, UK. 23. Southampton Clinical Trials Unit, University Hospital Southampton, Southampton, UK. 24. Louisiana State University and Medical Center, New Orleans, LA. 25. University Hospital Zurich, Zurich, Switzerland. 26. Agia Olga Hospital, Athens, Greece. 27. Royal Free Hospital NHS Trust, London, UK. 28. University of Pittsburgh, Pittsburgh, PA. 29. Mainz University Hospital, Mainz, Germany. 30. Mater hospital, Belfast, Northern Ireland. 31. Iwate Medical University, Morioka, Japan. 32. Mayo Clinic, Jacksonville, FL. 33. Hepatobiliary Centre-Paul Brousse Hospital, Villejuif-Paris, France.
Abstract
OBJECTIVE: The European Guidelines Meeting on Laparoscopic Liver Surgery was held in Southampton on February 10 and 11, 2017 with the aim of presenting and validating clinical practice guidelines for laparoscopic liver surgery. BACKGROUND: The exponential growth of laparoscopic liver surgery in recent years mandates the development of clinical practice guidelines to direct the speciality's continued safe progression and dissemination. METHODS: A unique approach to the development of clinical guidelines was adopted. Three well-validated methods were integrated: the Scottish Intercollegiate Guidelines Network methodology for the assessment of evidence and development of guideline statements; the Delphi method of establishing expert consensus, and the AGREE II-GRS Instrument for the assessment of the methodological quality and external validation of the final statements. RESULTS: Along with the committee chairman, 22 European experts; 7 junior experts and an independent validation committee of 11 international surgeons produced 67 guideline statements for the safe progression and dissemination of laparoscopic liver surgery. Each of the statements reached at least a 95% consensus among the experts and were endorsed by the independent validation committee. CONCLUSION: The European Guidelines Meeting for Laparoscopic Liver Surgery has produced a set of clinical practice guidelines that have been independently validated for the safe development and progression of laparoscopic liver surgery. The Southampton Guidelines have amalgamated the available evidence and a wealth of experts' knowledge taking in consideration the relevant stakeholders' opinions and complying with the international methodology standards.
OBJECTIVE: The European Guidelines Meeting on Laparoscopic Liver Surgery was held in Southampton on February 10 and 11, 2017 with the aim of presenting and validating clinical practice guidelines for laparoscopic liver surgery. BACKGROUND: The exponential growth of laparoscopic liver surgery in recent years mandates the development of clinical practice guidelines to direct the speciality's continued safe progression and dissemination. METHODS: A unique approach to the development of clinical guidelines was adopted. Three well-validated methods were integrated: the Scottish Intercollegiate Guidelines Network methodology for the assessment of evidence and development of guideline statements; the Delphi method of establishing expert consensus, and the AGREE II-GRS Instrument for the assessment of the methodological quality and external validation of the final statements. RESULTS: Along with the committee chairman, 22 European experts; 7 junior experts and an independent validation committee of 11 international surgeons produced 67 guideline statements for the safe progression and dissemination of laparoscopic liver surgery. Each of the statements reached at least a 95% consensus among the experts and were endorsed by the independent validation committee. CONCLUSION: The European Guidelines Meeting for Laparoscopic Liver Surgery has produced a set of clinical practice guidelines that have been independently validated for the safe development and progression of laparoscopic liver surgery. The Southampton Guidelines have amalgamated the available evidence and a wealth of experts' knowledge taking in consideration the relevant stakeholders' opinions and complying with the international methodology standards.